152 related articles for article (PubMed ID: 22119063)
1. Four-year clinical outcomes of the OLIVUS-Ex (impact of Olmesartan on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) extension trial.
Hirohata A; Yamamoto K; Miyoshi T; Hatanaka K; Hirohata S; Yamawaki H; Komatsubara I; Hirose E; Kobayashi Y; Ohkawa K; Ohara M; Takafuji H; Sano F; Toyama Y; Kusachi S; Ohe T; Ito H
Atherosclerosis; 2012 Jan; 220(1):134-8. PubMed ID: 22119063
[TBL] [Abstract][Full Text] [Related]
2. Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial.
Hirohata A; Yamamoto K; Miyoshi T; Hatanaka K; Hirohata S; Yamawaki H; Komatsubara I; Murakami M; Hirose E; Sato S; Ohkawa K; Ishizawa M; Yamaji H; Kawamura H; Kusachi S; Murakami T; Hina K; Ohe T
J Am Coll Cardiol; 2010 Mar; 55(10):976-82. PubMed ID: 20202514
[TBL] [Abstract][Full Text] [Related]
3. Olmesartan reduces inflammatory biomarkers in patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the OLIVUS trial.
Miyoshi T; Hirohata A; Usui S; Yamamoto K; Murakami T; Komatsubara I; Kusachi S; Ohe T; Nakamura K; Ito H
Heart Vessels; 2014 Mar; 29(2):178-85. PubMed ID: 23563752
[TBL] [Abstract][Full Text] [Related]
4. Impact of angiotensin II receptor blocker therapy (olmesartan or valsartan) on coronary atherosclerotic plaque volume measured by intravascular ultrasound in patients with stable angina pectoris.
Ishii H; Kobayashi M; Kurebayashi N; Yoshikawa D; Suzuki S; Ichimiya S; Kanashiro M; Sone T; Tsuboi H; Amano T; Uetani T; Harada K; Marui N; Murohara T
Am J Cardiol; 2013 Aug; 112(3):363-8. PubMed ID: 23623047
[TBL] [Abstract][Full Text] [Related]
5. Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents.
Claessen BE; Mehran R; Mintz GS; Weisz G; Leon MB; Dogan O; de Ribamar Costa J; Stone GW; Apostolidou I; Morales A; Chantziara V; Syros G; Sanidas E; Xu K; Tijssen JG; Henriques JP; Piek JJ; Moses JW; Maehara A; Dangas GD
JACC Cardiovasc Interv; 2011 Sep; 4(9):974-81. PubMed ID: 21939937
[TBL] [Abstract][Full Text] [Related]
6. Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes.
Lansky AJ; Ng VG; Maehara A; Weisz G; Lerman A; Mintz GS; De Bruyne B; Farhat N; Niess G; Jankovic I; Lazar D; Xu K; Fahy M; Serruys PW; Stone GW
JACC Cardiovasc Imaging; 2012 Mar; 5(3 Suppl):S62-72. PubMed ID: 22421232
[TBL] [Abstract][Full Text] [Related]
7. Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial.
Hibi K; Kimura T; Kimura K; Morimoto T; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
Atherosclerosis; 2011 Dec; 219(2):743-9. PubMed ID: 21899843
[TBL] [Abstract][Full Text] [Related]
8. Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUS.
Puri R; Nissen SE; Menon V; Shao M; Hsu A; Bakris GL; Kastelein JJ; Williams B; Armbrecht J; Brunel P; Kataoka Y; Nicholls SJ
Atherosclerosis; 2015 Dec; 243(2):553-9. PubMed ID: 26523993
[TBL] [Abstract][Full Text] [Related]
9. Coronary plaque progression of non-culprit lesions after culprit percutaneous coronary intervention in patients with moderate to advanced chronic kidney disease: intravascular ultrasound and integrated backscatter intravascular ultrasound study.
Kashiyama K; Sonoda S; Muraoka Y; Suzuki Y; Kamezaki F; Tsuda Y; Araki M; Tamura M; Takeuchi M; Abe H; Okazaki M; Fujino Y; Otsuji Y
Int J Cardiovasc Imaging; 2015 Jun; 31(5):935-45. PubMed ID: 25724567
[TBL] [Abstract][Full Text] [Related]
10. Effects of valsartan, an angiotensin II receptor blocker, on coronary atherosclerosis in patients with acute myocardial infarction who receive an angiotensin-converting enzyme inhibitor.
Yano H; Hibi K; Nozawa N; Ozaki H; Kusama I; Ebina T; Kosuge M; Tsukahara K; Okuda J; Morita S; Umemura S; Kimura K
Circ J; 2012; 76(6):1442-51. PubMed ID: 22473458
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of percutaneous coronary intervention in intermediate coronary artery disease: fractional flow reserve-guided versus intravascular ultrasound-guided.
Nam CW; Yoon HJ; Cho YK; Park HS; Kim H; Hur SH; Kim YN; Chung IS; Koo BK; Tahk SJ; Fearon WF; Kim KB
JACC Cardiovasc Interv; 2010 Aug; 3(8):812-7. PubMed ID: 20723852
[TBL] [Abstract][Full Text] [Related]
12. Residual plaque burden in patients with acute coronary syndromes after successful percutaneous coronary intervention.
McPherson JA; Maehara A; Weisz G; Mintz GS; Cristea E; Mehran R; Foster M; Verheye S; Rabbani L; Xu K; Fahy M; Templin B; Zhang Z; Lansky AJ; de Bruyne B; Serruys PW; Stone GW
JACC Cardiovasc Imaging; 2012 Mar; 5(3 Suppl):S76-85. PubMed ID: 22421234
[TBL] [Abstract][Full Text] [Related]
13. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
[TBL] [Abstract][Full Text] [Related]
14. Plaque burden with composition? That is the next question.
Marso SP
J Am Coll Cardiol; 2010 Mar; 55(10):983-5. PubMed ID: 20202515
[No Abstract] [Full Text] [Related]
15. A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years.
Serruys PW; Farooq V; Vranckx P; Girasis C; Brugaletta S; Garcia-Garcia HM; Holmes DR; Kappetein AP; Mack MJ; Feldman T; Morice MC; Ståhle E; James S; Colombo A; Pereda P; Huang J; Morel MA; Van Es GA; Dawkins KD; Mohr FW; Steyerberg EW
JACC Cardiovasc Interv; 2012 Jun; 5(6):606-17. PubMed ID: 22721655
[TBL] [Abstract][Full Text] [Related]
16. Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes.
Marso SP; Mercado N; Maehara A; Weisz G; Mintz GS; McPherson J; Schiele F; Dudek D; Fahy M; Xu K; Lansky A; Templin B; Zhang Z; de Bruyne B; Serruys PW; Stone GW
JACC Cardiovasc Imaging; 2012 Mar; 5(3 Suppl):S42-52. PubMed ID: 22421230
[TBL] [Abstract][Full Text] [Related]
17. Impact of angiographic and intravascular ultrasound features on clinical outcome after sirolimus-eluting stent implantation for de-novo lesions in nondiabetic and type 2 diabetic patients.
Du R; Zhang RY; Zhu ZB; Zhang Q; Hu J; Yang ZK; Yan ZJ; Lv AK; Ding FH; Zhang JS; Shen WF
Coron Artery Dis; 2010 May; 21(3):175-81. PubMed ID: 20305549
[TBL] [Abstract][Full Text] [Related]
18. Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil.
Mason RP
Vasc Health Risk Manag; 2011; 7():405-16. PubMed ID: 21796255
[TBL] [Abstract][Full Text] [Related]
19. Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) Study.
Calvert PA; Obaid DR; O'Sullivan M; Shapiro LM; McNab D; Densem CG; Schofield PM; Braganza D; Clarke SC; Ray KK; West NE; Bennett MR
JACC Cardiovasc Imaging; 2011 Aug; 4(8):894-901. PubMed ID: 21835382
[TBL] [Abstract][Full Text] [Related]
20. Long-term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS.
Jakabcin J; Spacek R; Bystron M; Kvasnák M; Jager J; Veselka J; Kala P; Cervinka P
Catheter Cardiovasc Interv; 2010 Mar; 75(4):578-83. PubMed ID: 19902491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
